Suppr超能文献

纵向群体药代动力学研究中的平衡设计

Balanced designs in longitudinal population pharmacokinetic studies.

作者信息

Ette E I, Sun H, Ludden T M

机构信息

Vertex Pharmaceuticals, Cambridge, Massachusetts 02139, USA

出版信息

J Clin Pharmacol. 1998 May;38(5):417-23. doi: 10.1002/j.1552-4604.1998.tb04446.x.

Abstract

A simulation study was performed using a balanced design to determine the sample size required for accurate and precise estimation of a parameter at a given level of intersubject variability in a longitudinal population pharmacokinetic study. A two-compartment model parameterized in terms of clearance (Cl), volumes of the central (V1) and peripheral (V2) compartments, and intercompartmental clearance (Q) with multiple intravenous bolus inputs was assumed. Six samples were obtained from each subject using the informative profile (block) randomized design. Variability (in terms of coefficient of variation, CV) in model parameters was varied between 30% and 100%, and residual variability was fixed at 15%. Sample sizes ranging from 30 to 1,000 subjects were studied, and a hundred replicate data sets were generated and analyzed with NONMEM for each sample size at each CV. A sample size of 30 was required for accurate and precise estimation of structural model parameters when CV < or = 75%, except for Cl where it is adequate for CV < or = 100%. A sample size of 80 was required for intersubject variability estimation with CV < or = 60%. Robust estimates of variability in Cl were obtained with sample sizes of 30 (CV < or = 45%), 60 (CV 60-75%), and 100 (CV > or = 75%). Positively biased estimates of residual variability were obtained irrespective of sample size at > or = 60% CV. This indicates that estimates of residual variability obtained in study situations where CV > or = 60% should be interpreted with caution. In such situations model misspecification may not be the issue, because in this simulation study concentration-time profiles were generated and analyzed with the same model. Although these results should be interpreted within the context of the study, they provide a framework for addressing the issue of sample size in longitudinal population pharmacokinetic study with a balanced sampling design. The result of a population pharmacokinetic study can be anticipated by comparing the results of several simulations in which the various input factors have been varied.

摘要

在一项纵向群体药代动力学研究中,使用平衡设计进行了模拟研究,以确定在给定的个体间变异性水平下,准确且精确地估计一个参数所需的样本量。假定采用多剂量静脉推注输入,建立了一个以清除率(Cl)、中央室体积(V1)、外周室体积(V2)和室间清除率(Q)参数化的二室模型。采用信息性轮廓(区组)随机设计,从每个受试者获取6个样本。模型参数的变异性(以变异系数,CV表示)在30%至100%之间变化,残余变异性固定为15%。研究了样本量从30至1000名受试者的情况,针对每个CV下的每个样本量,生成并使用NONMEM分析了一百个重复数据集。当CV≤75%时,准确且精确地估计结构模型参数需要30个样本量,Cl除外,其在CV≤100%时足够。当CV≤60%时,估计个体间变异性需要80个样本量。对于Cl变异性的稳健估计,样本量为30(CV≤45%)、60(CV 60 - 75%)和100(CV≥75%)时可以获得。当CV≥60%时,无论样本量如何,都会获得残余变异性的正偏差估计。这表明在CV≥60%的研究情况下获得的残余变异性估计应谨慎解释。在这种情况下,模型错误指定可能不是问题,因为在本模拟研究中,浓度 - 时间曲线是使用相同模型生成和分析的。尽管这些结果应在研究背景下进行解释,但它们为采用平衡抽样设计的纵向群体药代动力学研究中解决样本量问题提供了一个框架。通过比较几个改变了各种输入因素的模拟结果,可以预测群体药代动力学研究的结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验